TENET HEALTHCARE CORP (THC) Stock Analyst Ratings
USA • New York Stock Exchange • NYSE:THC • US88033G4073
201.37 USD
+5.4 (+2.76%)
At close: Feb 6, 2026
201.37 USD
0 (0%)
After Hours: 2/6/2026, 8:08:22 PM
ChartMill assigns a Buy % Consensus number of 81% to THC. The Buy consensus is the weighted average rating of the current analysts ratings.
- Analysts have set a mean price target forecast of 240.39. This target is 19.37% above the current price.
- THC was analyzed by 28 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about THC.
- In the previous month the buy percentage consensus was at a similar level.
- THC was analyzed by 28 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-03 | RBC Capital | Maintains | Outperform -> Outperform |
| 2026-01-07 | TD Cowen | Maintains | Buy -> Buy |
| 2026-01-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-02 | Guggenheim | Maintains | Buy -> Buy |
| 2025-11-21 | Barclays | Maintains | Overweight -> Overweight |
| 2025-11-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-11-13 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-11-03 | Truist Securities | Reiterate | Buy -> Buy |
| 2025-10-30 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-10-29 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-10-29 | Guggenheim | Maintains | Buy -> Buy |
| 2025-10-29 | UBS | Maintains | Buy -> Buy |
| 2025-10-17 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-10-08 | Keybanc | Maintains | Overweight -> Overweight |
| 2025-10-07 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-10-07 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-09-18 | Barclays | Maintains | Overweight -> Overweight |
| 2025-09-10 | B of A Securities | Maintains | Buy -> Buy |
| 2025-08-26 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-08-14 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-08-04 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-07-28 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2025-07-25 | Baird | Maintains | Neutral -> Neutral |
| 2025-07-24 | Barclays | Maintains | Overweight -> Overweight |
| 2025-07-23 | Guggenheim | Maintains | Buy -> Buy |
| 2025-07-23 | UBS | Maintains | Buy -> Buy |
| 2025-07-23 | Raymond James | Reiterate | Outperform -> Outperform |
| 2025-07-16 | Truist Securities | Maintains | Buy -> Buy |
| 2025-07-11 | Mizuho | Maintains | Outperform -> Outperform |
| 2025-06-09 | Morgan Stanley | Maintains | Overweight -> Overweight |
TENET HEALTHCARE CORP / THC FAQ
What is the average price target for TENET HEALTHCARE CORP (THC) stock?
28 analysts have analysed THC and the average price target is 240.39 USD. This implies a price increase of 19.37% is expected in the next year compared to the current price of 201.37.
Can you provide the consensus rating for TENET HEALTHCARE CORP stock?
The consensus rating for TENET HEALTHCARE CORP (THC) is 81.4286 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover TENET HEALTHCARE CORP (THC) stock?
The number of analysts covering TENET HEALTHCARE CORP (THC) is 28.